• This record comes from PubMed

Enzyme Tunnels and Gates As Relevant Targets in Drug Design

. 2017 Sep ; 37 (5) : 1095-1139. [epub] 20161213

Language English Country United States Media print-electronic

Document type Journal Article, Review, Research Support, Non-U.S. Gov't

Many enzymes contain tunnels and gates that are essential to their function. Gates reversibly switch between open and closed conformations and thereby control the traffic of small molecules-substrates, products, ions, and solvent molecules-into and out of the enzyme's structure via molecular tunnels. Many transient tunnels and gates undoubtedly remain to be identified, and their functional roles and utility as potential drug targets have received comparatively little attention. Here, we describe a set of general concepts relating to the structural properties, function, and classification of these interesting structural features. In addition, we highlight the potential of enzyme tunnels and gates as targets for the binding of small molecules. The different types of binding that are possible and the potential pharmacological benefits of such targeting are discussed. Twelve examples of ligands bound to the tunnels and/or gates of clinically relevant enzymes are used to illustrate the different binding modes and to explain some new strategies for drug design. Such strategies could potentially help to overcome some of the problems facing medicinal chemists and lead to the discovery of more effective drugs.

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

MOLEonline: a web-based tool for analysing channels, tunnels, and pores (2025 update)

. 2025 Sep 01 ; 41 (9) : .

Large-scale annotation of biochemically relevant pockets and tunnels in cognate enzyme-ligand complexes

. 2024 Oct 15 ; 16 (1) : 114. [epub] 20241015

Fully automated virtual screening pipeline of FDA-approved drugs using Caver Web

. 2022 ; 20 () : 6512-6518. [epub] 20221117

Screening of world approved drugs against highly dynamical spike glycoprotein of SARS-CoV-2 using CaverDock and machine learning

. 2021 ; 19 () : 3187-3197. [epub] 20210526

Fast Screening of Inhibitor Binding/Unbinding Using Novel Software Tool CaverDock

. 2019 ; 7 () : 709. [epub] 20191029

Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport

. 2019 Jul 02 ; 47 (W1) : W414-W422.

CAVER Analyst 2.0: analysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories

. 2018 Oct 15 ; 34 (20) : 3586-3588.

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...